Global Transplantation Preservation Solutions Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

Transplantation Preservation Solutions Market Size

• The global transplantation preservation solutions market size was valued at USD 274.29 Million in 2024 and is expected to reach USD 437.18 Million by 2032, at a CAGR of 6.00% during the forecast period
• The market growth is largely fueled by the increasing demand for organ and tissue transplantation worldwide, coupled with technological advancements in preservation solutions that improve the viability and shelf-life of organs. Improved formulations and specialized storage solutions are enhancing the success rates of transplants, making these solutions critical for healthcare providers and transplant centers
• Furthermore, rising awareness among healthcare professionals and patients regarding the importance of maintaining organ quality during transport and storage is driving the adoption of advanced transplantation preservation solutions. Hospitals, specialty clinics, and organ banks are increasingly integrating innovative solutions that ensure optimal preservation, reduce ischemic damage, and improve patient outcomes. These converging factors are accelerating the uptake of transplantation preservation solutions, thereby significantly boosting the market’s growth

Transplantation Preservation Solutions Market Analysis

• Transplantation Preservation Solutions are critical for maintaining the viability and quality of organs, tissues, and cells during transportation and storage, ensuring successful transplantation outcomes in both clinical and research settings. These solutions help reduce ischemic injury, maintain cellular integrity, and improve overall graft survival rates
• The market growth is primarily driven by the rising number of organ transplants globally, increasing prevalence of end-stage organ failures, and growing awareness among healthcare providers about the importance of high-quality preservation solutions. Advanced research in organ storage and transportation technologies further supports market expansion
• North America dominated the transplantation preservation solutions market with the largest revenue share of 45.8% in 2024, supported by advanced healthcare infrastructure, high organ transplant rates, and the presence of major market players. The U.S. leads within the region, driven by innovations in preservation solutions, adoption of new technologies in hospitals and transplant centers, and a strong network of organ procurement organizations
• Asia-Pacific is expected to be the fastest-growing region in the transplantation preservation solutions market during the forecast period, fueled by increasing urbanization, rising healthcare investments, growing number of transplant procedures, and expanding awareness about organ preservation standards in countries such as China, India, and Japan
• The Kidneys segment dominated the transplantation preservation solutions market with a revenue share of 51.2% in 2024, as kidney transplants remain the most commonly performed organ transplants worldwide

Report Scope and Transplantation Preservation Solutions Market Segmentation     

Transplantation Preservation Solutions Market Trends

Growing Focus on Enhanced Organ Viability and Preservation Technologies

• A significant and accelerating trend in the global transplantation preservation solutions market is the increasing adoption of advanced preservation technologies that extend organ viability and improve transplantation outcomes. These solutions are crucial in reducing ischemic damage, ensuring organ functionality, and expanding the donor pool for critical transplants
  • For instance, innovative hypothermic and normothermic perfusion systems are being integrated into hospital transplant programs, allowing continuous monitoring of organ condition and better preservation of heart, liver, kidney, and lung tissues during transportation. Similarly, novel preservation solutions with optimized chemical compositions are improving tissue stability and reducing oxidative stress
• Advanced organ preservation technologies enable better compatibility assessment, improved post-transplant recovery, and reduced risk of graft failure. Research and development in the field are leading to solutions that can maintain organs for longer durations while minimizing cellular damage. Hospitals and transplant centers increasingly rely on these solutions to enhance patient outcomes and operational efficiency
• The seamless integration of preservation solutions with existing hospital infrastructure, including specialized storage units and transport systems, facilitates centralized monitoring and standardized protocols for organ handling. This ensures consistent quality and safety during the entire transplantation process
• This trend towards more effective, reliable, and standardized transplantation preservation solutions is fundamentally reshaping clinical expectations in organ transplantation. Consequently, companies such as OrganOx, XVIVO Perfusion, and Bridge to Life are developing innovative solutions that maximize organ viability and expand transplant possibilities
• The demand for advanced transplantation preservation solutions is growing rapidly across both developed and emerging markets, as hospitals and transplant centers increasingly prioritize patient outcomes, reduce organ wastage, and adopt solutions that ensure safer, more efficient transplantation procedures

Transplantation Preservation Solutions Market Dynamics

Driver

Growing Need Due to Rising Organ Transplantation and Technological Advancements

• The increasing prevalence of end-stage organ failures, rising number of organ transplants, and growing awareness among healthcare providers about proper organ preservation are key drivers for the heightened demand for Transplantation Preservation Solutions
  • For instance, In April 2024, Paragonix Technologies announced its participation in the American Transplant Congress (ATC) 2024 in Philadelphia, unveiling enhancements to its SherpaPak Cardiac Transport System, including real-time temperature analytics and integrated digital tracking. The company also revealed a strategic partnership with Bridge to Life Ltd. during the event to co-develop next-generation organ transport solutions
• As healthcare providers and transplant centers focus on improving transplantation outcomes, high-quality preservation solutions offer reliable maintenance of organ integrity, reduce ischemic damage, and enhance graft survival rates, providing a compelling benefit over traditional storage methods
• Furthermore, the adoption of advanced preservation solutions with temperature monitoring, perfusion technologies, and real-time quality tracking is increasing across hospitals, specialty clinics, and research facilities, making these solutions an integral part of modern transplantation protocols
• The growing emphasis on patient safety, coupled with regulatory guidelines for organ preservation, and the need for seamless integration of preservation technologies into clinical workflows, are key factors propelling the adoption of Transplantation Preservation Solutions in both developed and emerging markets

Restraint/Challenge

Concerns Regarding High Costs and Operational Complexity

• The relatively high initial cost of advanced transplantation preservation solutions systems compared to conventional storage methods poses a significant barrier to adoption, particularly in developing regions or budget-constrained healthcare facilities
• Complexity in handling and operating some sophisticated preservation technologies, such as perfusion devices or automated organ transport systems, may limit adoption among centers lacking trained personnel or technical expertise
• Addressing these challenges through cost-effective solutions, simplified operational protocols, and training programs for healthcare professionals is crucial for expanding market penetration. Leading companies are emphasizing user-friendly designs, reliability, and compliance with regulatory standards to reassure potential buyers
• While prices for basic preservation solutions are gradually decreasing, premium systems with advanced monitoring, perfusion, or real-time tracking features still carry a higher cost, which may slow adoption in price-sensitive markets
• Overcoming these challenges through technological innovation, workforce training, and the development of more affordable, reliable, and easy-to-use Transplantation Preservation Solutions will be vital for sustained market growth in the forecast period

Transplantation Preservation Solutions Market Scope

The market is segmented on the basis of technique, preservation solution, and organ type.

• By Technique

On the basis of technique, the global transplantation preservation solutions market is segmented into static cold storage, hypothermic perfusion preservation, and other techniques. The Hypothermic Perfusion Preservation segment dominated the market with a revenue share of 46.5% in 2024, owing to its unmatched capability to maintain organ viability and reduce ischemic injury during transport. This technique allows continuous circulation of preservation solution through the organ, offering real-time monitoring of organ function, which supports critical decision-making by surgeons. Hospitals and transplant centers prefer hypothermic perfusion for high-value organs such as kidneys and livers to maximize post-transplant success rates. The growing emphasis on minimizing organ wastage, improving graft survival, and enhancing clinical outcomes has further fueled adoption. Increasing availability of advanced perfusion systems, coupled with supportive healthcare policies, reinforces its leadership in the market.

The Static Cold Storage segment is projected to witness the fastest CAGR of 18.3% from 2025 to 2032, largely due to its cost-effectiveness, simplicity, and suitability for short-term organ transport. Static cold storage remains a preferred option in emergency transplants, small hospitals, and regions with limited infrastructure. Recent improvements in preservation solutions used in static storage, such as enhanced chemical formulations, have increased organ survival times. Expanding organ transplant programs in emerging markets, including India and China, are also driving rapid adoption. Its operational ease, low maintenance, and compatibility with multiple organ types make this technique highly attractive for healthcare providers globally.

• By Preservation Solution

On the basis of preservation solution, the global transplantation preservation solutions market is segmented into Viaspan, Custodiol HTK (Histidine-Tryptophan-Ketoglutarate), Renograf, Hypothermosol, Perfadex, Lifor, Human bioSystem (HBS) Solution, siRNA Transplant Solutions, and Others. The Viaspan segment held the largest market revenue share of 42.7% in 2024, attributed to its long-standing clinical reliability and wide regulatory acceptance across multiple regions. Viaspan is highly effective in preserving kidneys, livers, and hearts, minimizing cellular swelling and oxidative damage during transport. Hospitals and transplant centers favor it due to its compatibility with both hypothermic perfusion and static cold storage systems. The solution’s proven efficacy in improving post-transplant outcomes has cemented its position as the market leader. Strong global distribution networks, ease of integration into existing transplant workflows, and sustained R&D support contribute to its continued dominance.

The Custodiol HTK (Histidine-Tryptophan-Ketoglutarate) segment is projected to witness the fastest CAGR of 19.1% from 2025 to 2032, driven by increasing adoption in complex organ transplant procedures. HTK is particularly valued for reducing reperfusion injury in liver and heart transplants, enhancing long-term graft function. Growing clinical evidence, rising awareness among transplant surgeons, and expansion into emerging markets have significantly accelerated demand. Compatibility with hypothermic perfusion systems, long preservation times, and ability to support multi-organ transplants further support the rapid growth of this segment globally.

• By Organ Type

On the basis of organ type, the global transplantation preservation solutions market is segmented into Kidneys, Lung, Liver, Heart, and Others. The Kidneys segment dominated the market with a revenue share of 51.2% in 2024, as kidney transplants remain the most commonly performed organ transplants worldwide. The high prevalence of end-stage renal disease, increasing living and deceased donor transplants, and growing healthcare infrastructure drive strong demand. Hospitals prioritize preservation solutions and techniques that ensure maximum kidney viability and minimize delayed graft function. Awareness campaigns for organ donation, government initiatives, and the availability of advanced perfusion and preservation solutions all contribute to the segment’s leadership. Continuous improvements in preservation technologies have also reinforced kidney transplants as a key growth driver for the market.

The Liver segment is projected to witness the fastest CAGR of 17.8% from 2025 to 2032, driven by rising liver disease prevalence, hepatitis complications, and increasing surgical liver transplants. Advanced preservation solutions like HTK and hypothermic perfusion systems are being increasingly adopted to improve liver graft survival and post-transplant outcomes. Expansion of liver transplant programs in Asia-Pacific and the Middle East, coupled with growing hospital investments, supports rapid growth. The need for high-quality preservation methods and increased patient awareness of transplant options also contribute to this segment’s accelerating adoption.

Transplantation Preservation Solutions Market Regional Analysis

• North America dominated the transplantation preservation solutions market with the largest revenue share of 45.8% in 2024, supported by advanced healthcare infrastructure, high organ transplant rates, and the presence of major market players
• The region, driven by innovations in preservation solutions, adoption of new technologies in hospitals and transplant centers, and a strong network of organ procurement organizations
• The increasing prevalence of end-stage organ failures and rising awareness among healthcare providers about optimal organ preservation are further supporting market growth

U.S. Transplantation Preservation Solutions Market Insight

The U.S. transplantation preservation solutions market captured the largest share within North America in 2024, fueled by high organ transplant rates, advanced healthcare infrastructure, and a strong presence of key market players. Innovations in organ preservation technologies, such as perfusion systems, temperature-controlled storage solutions, and real-time monitoring devices, are driving adoption in hospitals and transplant centers. Additionally, a well-established network of organ procurement organizations and high patient awareness contribute to the country’s market leadership.

Europe Transplantation Preservation Solutions Market Insight

The Europe transplantation preservation solutions market is projected to grow steadily over the forecast period, driven by increasing organ transplant procedures, high healthcare standards, and regulatory support for quality organ preservation. Countries such as Germany and the U.K. are key contributors, with hospitals and specialty clinics increasingly adopting advanced preservation solutions to improve graft survival and transplantation outcomes.

U.K. Transplantation Preservation Solutions Market Insight

The U.K. transplantation preservation solutions market is expected to grow at a notable CAGR during the forecast period, fueled by rising organ transplant procedures, increasing hospital adoption of advanced preservation solutions, and growing awareness of organ preservation standards. The country’s robust healthcare system and established transplant networks support sustained market growth.

Germany Transplantation Preservation Solutions Market Insight

The Germany transplantation preservation solutions market is projected to expand at a considerable CAGR during the forecast period, driven by high organ transplant rates, advanced healthcare infrastructure, and increasing adoption of innovative preservation technologies. Hospitals and specialized transplant centers are the primary end-users, supported by strong regulatory frameworks and emphasis on quality standards.

Asia-Pacific Transplantation Preservation Solutions Market Insight

The Asia-Pacific transplantation preservation solutions market is expected to be the fastest-growing region in the transplantation preservation solutions market during the forecast period, fueled by increasing urbanization, rising healthcare investments, a growing number of transplant procedures, and expanding awareness about organ preservation standards in countries such as China, India, and Japan. The region is witnessing growing adoption of advanced organ preservation solutions in hospitals and specialty clinics to improve transplantation outcomes.

Japan Transplantation Preservation Solutions Market Insight

The Japan transplantation preservation solutions market is gaining momentum due to rising organ transplant procedures, high healthcare standards, and growing awareness about optimal organ preservation techniques. Hospitals and transplant centers are increasingly adopting advanced storage and transport solutions to maintain organ viability, while government initiatives and regulatory frameworks support market expansion.

China Transplantation Preservation Solutions Market Insight

The China transplantation preservation solutions market accounted for the largest revenue share in Asia-Pacific in 2024, driven by rapid urbanization, increasing healthcare investments, and rising organ transplant procedures. Growing awareness about organ preservation standards, coupled with the adoption of advanced preservation solutions in hospitals and transplant centers, is fueling market growth. The country’s expanding healthcare infrastructure and supportive government initiatives are further strengthening the market.

India Transplantation Preservation Solutions Market Insight

The India transplantation preservation solutions market is projected to grow significantly during the forecast period, driven by increasing organ transplant procedures, rising investments in healthcare infrastructure, and expanding awareness about organ preservation best practices. Adoption of advanced preservation solutions in hospitals and specialty clinics is increasing to improve graft survival and patient outcomes.

Transplantation Preservation Solutions Market Share

The transplantation preservation solutions industry is primarily led by well-established companies, including:

• XVIVO (Sweden)
• Paragonix Technologies, Inc. (U.S.)
• Bridge to Life Ltd. (U.S.)
• TransMedics, Inc. (U.S.)
• Dr. Franz Köhler Chemie GmbH (Germany)
• OrganOx Limited (U.K.)
• Preservation Solutions, Inc. (U.S.)
• Carnamedica S.P. (Poland)
• Shanghai Genext Medical Technology Co., Ltd. (China)
• Global Transplant Solutions, Inc. (U.S.)

Latest Developments in Global Transplantation Preservation Solutions Market

• In August 2025, Terumo Corporation, a leading Japanese medical technology company, acquired OrganOx Limited, a UK-based innovator in organ preservation technology, for USD 1.5 Million. OrganOx's metra platform, which employs normothermic machine perfusion (NMP) to preserve organs at near-body temperatures, has received regulatory approvals in the U.S., Europe, Canada, and Australia. This acquisition aims to enhance Terumo's portfolio in organ transplantation and expand the utilization of donor organs
• In August 2025, TransMedics, a U.S.-based company specializing in portable organ preservation systems, received FDA Investigational Device Exemption (IDE) approval to initiate the ENHANCE trial. This two-part clinical trial is designed to support the use of the Organ Care System (OCS) Heart for prolonged heart perfusion, potentially extending the preservation time and improving transplant outcomes
• In May 2025, Paragonix Technologies reported findings from the GUARDIAN-Lung Registry, indicating that the use of their advanced hypothermic lung preservation technologies led to statistically significant reductions in hospital readmissions and acute rejection rates following lung transplantation
• In August 2024, Getinge, a Swedish medical technology company, completed the acquisition of Paragonix Technologies for approximately USD 477 million. Paragonix's advanced organ preservation devices, which combine stable cooling techniques with digital tracking and monitoring, are expected to enhance Getinge's offerings in the organ transplant sector

SKU-44890